FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like DaVita Clinical Research Launches Alliance Site Network For Early Stage CKD Trials June 14, 2017 Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow November 29, 2017 Finally! STADA Arzneimittel Accepts $5.6 Billion Takeover Offer From Cinven April 9, 2017